Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review
@article{TCR59774, author = {Xiaojing Xu and Yiyi Yu and Mengling Liu and Li Liang and Tianshu Liu}, title = {Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review}, journal = {Translational Cancer Research}, volume = {11}, number = {1}, year = {2021}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/59774} }